Company / Shares Outstanding
UroGen Pharma Ltd. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
42.2M
FY2025
5-year range
22.2M / 42.2M
FY2021-FY2025
Trend
+30.0%
vs FY2024
Sector context
#180 of 212
Health Care
What the data says
UroGen Pharma Ltd.'s shares outstanding of 42231746.00 is lower than 85% of companies in the Health Care sector (FY2025). Shares Outstanding has increased for 9 consecutive years, from 2305503.00 in FY2016 to 42231746.00 in FY2025.
Based on SEC 10-K filings.
42231746.00 in FY2025 with a 5-year CAGR of +15.0%.
Increased from 23129953.00 to 42231746.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +23.4%
- 5-Year CAGR
- +15.0%
- 10-Year CAGR
- -
Sector benchmark
-86.2% below sector average
Key checks
Key Insights
- UroGen Pharma Ltd.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 30.0% year-over-year.
- Ranks #180 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 42.2M | +30.0% |
| FY2024 | 32.5M | +40.5% |
| FY2023 | 23.1M | +3.0% |
| FY2022 | 22.5M | +1.3% |
| FY2021 | 22.2M | +5.4% |
| FY2020 | 21.0M | +29.7% |
| FY2019 | 16.2M | +17.9% |
| FY2018 | 13.8M | +41.5% |
| FY2017 | 9.7M | +321.5% |
| FY2016 | 2.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026